id todo:paper_00257680_v58_n1_p29_Raimondi
record_format dspace
spelling todo:paper_00257680_v58_n1_p29_Raimondi2023-10-03T14:36:34Z Survery of medical specialists regarding asthma treatment Raimondi, G.A. Asthma Treatment beta adrenergic receptor stimulating agent corticosteroid steroid cromoglycate disodium nedocromil adult article asthma child human information processing inhalational drug administration physician adolescent desensitization drug choice health survey maintenance therapy major clinical study medical practice medical specialist nebulization oral drug administration parenteral drug administration practice guideline questionnaire school child steroid therapy Administration, Inhalation Adrenal Cortex Hormones Adrenergic beta-Agonists Adult Asthma Child Data Collection Humans Physicians Steroids A survey about asthma management was conducted in a group of 300 chest physicians randomized from a list of the whole country. This paper dealt with the questions about treatment in acute asthma and during maintenance therapy in adults and in children older than 6 years. Of the questionnaires mailed, 98 responses were obtained (32.7%)); 71% of the responders were respiratory medicine specialists (RM), 12% RM + Internal Medicine (IM), 6% in RM + Allergy (A), 5% in A, 4% in IM and 2% in IM + A. For the treatment of acute severe episodes 57.5% of the physicians chose nebulized or inhaled beta agonists (IBA) as the first choice for adults and 63.4% for children, parenteral steroids 26.3% in adults and 22 5% in children. For maintenance therapy, the first choice formulation was IBA for adults in 37.6% of the responders and inhaled steroid (IS) in 34.1% of them. In children, 34.7% of the responders choose IBA, 25.3% cromoglicate or nedocromil and 14.7% IS IBA were prescribed more commonly for treating symptoms, secondly for preventing symptoms and in third place for continuous preventive treatment in adults and in children. The recommendation of IBA for treating and preventing symptoms were more commonly done in children. The average normal daily dose of IS was 297 and 254 micrograms for adults and children, respectively. The average maximal dose was 1176 and 618 micrograms for adults and children, respectively. The recommendation of hyposensitization for allergic asthma was, as mean score of frequency of use (from O = never to 3 = always), 0.96 for adults and 1.13 for children. Important drawbacks were detected in the treatment approach. In acute asthma episodes about 40% of the responders did not use IBA as the first choice of treatment. For maintenance treatment IS were rarely used, and their doses were less than the usually recommended by different guidelines. IBA were seldom recommended for prevention or treatment of symptoms. They are used moderately as continuous preventive treatment. Hyposensitization is commonly recommended and more frequently used than in other countries. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00257680_v58_n1_p29_Raimondi
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Asthma
Treatment
beta adrenergic receptor stimulating agent
corticosteroid
steroid
cromoglycate disodium
nedocromil
adult
article
asthma
child
human
information processing
inhalational drug administration
physician
adolescent
desensitization
drug choice
health survey
maintenance therapy
major clinical study
medical practice
medical specialist
nebulization
oral drug administration
parenteral drug administration
practice guideline
questionnaire
school child
steroid therapy
Administration, Inhalation
Adrenal Cortex Hormones
Adrenergic beta-Agonists
Adult
Asthma
Child
Data Collection
Humans
Physicians
Steroids
spellingShingle Asthma
Treatment
beta adrenergic receptor stimulating agent
corticosteroid
steroid
cromoglycate disodium
nedocromil
adult
article
asthma
child
human
information processing
inhalational drug administration
physician
adolescent
desensitization
drug choice
health survey
maintenance therapy
major clinical study
medical practice
medical specialist
nebulization
oral drug administration
parenteral drug administration
practice guideline
questionnaire
school child
steroid therapy
Administration, Inhalation
Adrenal Cortex Hormones
Adrenergic beta-Agonists
Adult
Asthma
Child
Data Collection
Humans
Physicians
Steroids
Raimondi, G.A.
Survery of medical specialists regarding asthma treatment
topic_facet Asthma
Treatment
beta adrenergic receptor stimulating agent
corticosteroid
steroid
cromoglycate disodium
nedocromil
adult
article
asthma
child
human
information processing
inhalational drug administration
physician
adolescent
desensitization
drug choice
health survey
maintenance therapy
major clinical study
medical practice
medical specialist
nebulization
oral drug administration
parenteral drug administration
practice guideline
questionnaire
school child
steroid therapy
Administration, Inhalation
Adrenal Cortex Hormones
Adrenergic beta-Agonists
Adult
Asthma
Child
Data Collection
Humans
Physicians
Steroids
description A survey about asthma management was conducted in a group of 300 chest physicians randomized from a list of the whole country. This paper dealt with the questions about treatment in acute asthma and during maintenance therapy in adults and in children older than 6 years. Of the questionnaires mailed, 98 responses were obtained (32.7%)); 71% of the responders were respiratory medicine specialists (RM), 12% RM + Internal Medicine (IM), 6% in RM + Allergy (A), 5% in A, 4% in IM and 2% in IM + A. For the treatment of acute severe episodes 57.5% of the physicians chose nebulized or inhaled beta agonists (IBA) as the first choice for adults and 63.4% for children, parenteral steroids 26.3% in adults and 22 5% in children. For maintenance therapy, the first choice formulation was IBA for adults in 37.6% of the responders and inhaled steroid (IS) in 34.1% of them. In children, 34.7% of the responders choose IBA, 25.3% cromoglicate or nedocromil and 14.7% IS IBA were prescribed more commonly for treating symptoms, secondly for preventing symptoms and in third place for continuous preventive treatment in adults and in children. The recommendation of IBA for treating and preventing symptoms were more commonly done in children. The average normal daily dose of IS was 297 and 254 micrograms for adults and children, respectively. The average maximal dose was 1176 and 618 micrograms for adults and children, respectively. The recommendation of hyposensitization for allergic asthma was, as mean score of frequency of use (from O = never to 3 = always), 0.96 for adults and 1.13 for children. Important drawbacks were detected in the treatment approach. In acute asthma episodes about 40% of the responders did not use IBA as the first choice of treatment. For maintenance treatment IS were rarely used, and their doses were less than the usually recommended by different guidelines. IBA were seldom recommended for prevention or treatment of symptoms. They are used moderately as continuous preventive treatment. Hyposensitization is commonly recommended and more frequently used than in other countries.
format JOUR
author Raimondi, G.A.
author_facet Raimondi, G.A.
author_sort Raimondi, G.A.
title Survery of medical specialists regarding asthma treatment
title_short Survery of medical specialists regarding asthma treatment
title_full Survery of medical specialists regarding asthma treatment
title_fullStr Survery of medical specialists regarding asthma treatment
title_full_unstemmed Survery of medical specialists regarding asthma treatment
title_sort survery of medical specialists regarding asthma treatment
url http://hdl.handle.net/20.500.12110/paper_00257680_v58_n1_p29_Raimondi
work_keys_str_mv AT raimondiga surveryofmedicalspecialistsregardingasthmatreatment
_version_ 1782027997915643904